Fresenius Medical Care (FMS) Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Mar 31, 2026: 1 added, 2 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about FMS filings

Are insiders buying or selling Fresenius Medical Care Corporation (FMS) stock?

Neither. Fresenius Medical Care Corporation (FMS) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded FMS recently?

None. No member of Congress disclosed a FMS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this FMS smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

17 funds hold a position.

Questions about FMS filings

Are insiders buying or selling Fresenius Medical Care Corporation (FMS) stock?

Neither. Fresenius Medical Care Corporation (FMS) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded FMS recently?

None. No member of Congress disclosed a FMS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this FMS smart-money data?

Checking federal contract awards

Other smart money signals

Activist stakes, short interest & more

2 items

F1
Filing 13d GModerate
Fresenius SE & Co. KGaA filed SC 13D/A on Fresenius Medical Care AG (activist 20.9% stake)
SI
Short Interest ChangeModerate
short-volume tape softening: latest 38.8% fell 14.4pp vs 20d avg 53.2%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 3, 2026

Earnings came in 20.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 3, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.64+20.75% beat

$0.53 expected

Revenue

EUR 4.94B

SEC filing

Next report

What the street expects next

Estimates as of Nov 9, 2026

EPS expected

$0.37

$0.37 to $0.37

Revenue expected

$5.15B

5 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.19

Change in 30 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 3, 2026	$0.64est. $0.53	+20.75%beat	EUR 4.94BSEC filing	+1.1%from EUR 4.88B
Jun 30, 2026Reported Aug 3, 2026	$0.66est. $0.50	+32.00%beat	EUR 4.86BSEC filing	+1.4%from EUR 4.79B
Mar 31, 2026Reported May 5, 2026	$0.46est. $0.53	-13.58%miss	EUR 4.61BAlpha Vantage	-5.5%from EUR 4.88B
Dec 31, 2025Reported Feb 24, 2026	$0.72est. $0.55	+30.91%beat	EUR 5.07BAlpha Vantage	-0.3%from EUR 5.08B
Sep 30, 2025Reported Nov 4, 2025	$0.55est. $0.50	+10.00%beat	EUR 4.88BSEC filing	+2.6%from EUR 4.76B
Jun 30, 2025Reported Aug 5, 2025	$0.46est. $0.47	-2.13%miss	EUR 4.79BSEC filing	+0.5%from EUR 4.77B
Mar 31, 2025Reported May 6, 2025	$0.42est. $0.38	+10.53%beat	EUR 4.88BSEC filing	+3.3%from EUR 4.72B
Dec 31, 2024Reported Feb 25, 2025	$0.46est. $0.40	+13.61%beat	EUR 5.08BAlpha Vantage	+1.9%from EUR 4.99B

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $22.27
High: $22.30
Low: $21.57
Prev close: $22.22
52-wk high: $26.42
52-wk low: $19.24
Mkt cap: $11.45B
P/E: 12.8x
ROE: +7.8%
Fwd P/E: 9.7x
Beta: 0.79
Div yield: 4.04%
P/S: 0.6x
P/B: 0.8x
Profit margin: +4.2%
Op margin: +10.1%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 4.2%
P/E: 12.75
Forward P/E: 9.71
Market cap: $11.4B

Valuation

P/S0.59
P/B0.80
Dividend yield4.0%

Quality

Operating margin10.1%
ROE7.8%
ROA3.9%

Growth

Beta0.79

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

42balanced

20D volatility

39%annualized

52-week range

$21.59

$19.24$26.42

20D support

$20.91recent floor

20D resistance

$23.83recent ceiling

Returns

5D -8.7%20D -2.4%60D -9.4%

Price vs moving averages

SMA20 -3.9%SMA50 -3.2%SMA200 -4.3%

Volume pace

1.71xvs prior 20D

12 macro signals shaping FMS right now

Unlock sector rotation, regime shifts, and macro event windows tied to this stock.

Unlock the full results

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 3, 2026

$0.64est. $0.53

+20.75%

EUR 4.94BSEC filing

+1.1%from EUR 4.88B

Jun 30, 2026Aug 3, 2026

$0.66est. $0.50

+32.00%

EUR 4.86BSEC filing

+1.4%from EUR 4.79B

Mar 31, 2026May 5, 2026

$0.46est. $0.53

-13.58%

EUR 4.61BAlpha Vantage

-5.5%from EUR 4.88B

Dec 31, 2025Feb 24, 2026

$0.72est. $0.55

+30.91%

EUR 5.07BAlpha Vantage

-0.3%from EUR 5.08B

Sep 30, 2025Nov 4, 2025

$0.55est. $0.50

+10.00%

EUR 4.88BSEC filing

+2.6%from EUR 4.76B

Jun 30, 2025Aug 5, 2025

$0.46est. $0.47

-2.13%

EUR 4.79BSEC filing

+0.5%from EUR 4.77B

Mar 31, 2025May 6, 2025

$0.42est. $0.38

+10.53%

EUR 4.88BSEC filing

+3.3%from EUR 4.72B

Dec 31, 2024Feb 25, 2025

$0.46est. $0.40

+13.61%

EUR 5.08BAlpha Vantage

+1.9%from EUR 4.99B

Fresenius Medical Care Corporation

Smart money at a glance

What do analysts expect?

Questions about FMS filings

Questions about FMS filings

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in 20.8% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Fresenius Medical Care Corporation

Smart money at a glance

What do analysts expect?

Questions about FMS filings

Questions about FMS filings

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in 20.8% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Fresenius Medical Care Corporation

Overview

Questions about FMS filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.

Fresenius Medical Care Corporation

Overview

Questions about FMS filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.